Loading...
Psychemedics Corporation
PMD•NASDAQ
Healthcare
Medical - Diagnostics & Research
$2.67
$0.00(0.00%)
Psychemedics Corporation (PMD) Financial Performance & Income Statement Overview
Review Psychemedics Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-10.92%
↓ 10.92%
Operating Income Growth
35.19%
↑ 35.19%
Net Income Growth
55.20%
↑ 55.20%
Operating Cash Flow Growth
162.77%
↑ 162.77%
Operating Margin
-9.62%
↓ 9.62%
Gross Margin
36.07%
↑ 36.07%
Net Profit Margin
-9.45%
↓ 9.45%
ROE
-32.94%
↓ 32.94%
ROIC
-33.76%
↓ 33.76%
Psychemedics Corporation (PMD) Income Statement & Financial Overview
Review Psychemedics Corporation's (PMD) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $4.42M | $5.17M | $4.73M | $5.36M |
| Cost of Revenue | $3.04M | $3.14M | $3.18M | $3.23M |
| Gross Profit | $1.39M | $2.04M | $1.55M | $2.12M |
| Gross Profit Ratio | $0.31 | $0.39 | $0.33 | $0.40 |
| R&D Expenses | $179000.00 | $172000.00 | $189000.00 | $209000.00 |
| SG&A Expenses | $1.04M | $2.46M | $2.26M | $2.48M |
| Operating Expenses | $1.22M | $2.63M | $2.45M | $2.69M |
| Total Costs & Expenses | $4.26M | $5.77M | $5.63M | $5.92M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $413000.00 | $0.00 | $664000.00 | $551000.00 |
| EBITDA | $584000.00 | -$595000.00 | -$235000.00 | -$21000.00 |
| EBITDA Ratio | $0.13 | -$0.11 | -$0.05 | -$0.004 |
| Operating Income | $168000.00 | -$595000.00 | -$899000.00 | -$567000.00 |
| Operating Income Ratio | $0.04 | -$0.11 | -$0.19 | -$0.11 |
| Other Income/Expenses (Net) | -$8000.00 | -$11000.00 | $1000.00 | -$5000.00 |
| Income Before Tax | $160000.00 | -$606000.00 | -$898000.00 | -$572000.00 |
| Income Before Tax Ratio | $0.04 | -$0.12 | -$0.19 | -$0.11 |
| Income Tax Expense | -$29000.00 | -$71000.00 | -$71000.00 | $116000.00 |
| Net Income | $189000.00 | -$535000.00 | -$827000.00 | -$688000.00 |
| Net Income Ratio | $0.04 | -$0.10 | -$0.17 | -$0.13 |
| EPS | $0.03 | -$0.09 | -$0.14 | -$0.12 |
| Diluted EPS | $0.03 | -$0.09 | -$0.14 | -$0.12 |
| Weighted Avg Shares Outstanding | $5.89M | $5.89M | $5.82M | $5.81M |
| Weighted Avg Shares Outstanding (Diluted) | $5.89M | $5.89M | $5.82M | $5.81M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan